Paul O’Nion joins RSSL

To head the expansion of gas chromatography and mass spectrometry services

Paul O'Nion has joined the pharmaceutical department at RSSL to head the gas chromatography team, and to oversee expansion of RSSL's gas chromatography – mass spectrometry (GC-MS) services. GC-MS technology is used in the investigation of trace levels of contamination, and other impurities in pharmaceutical products.

O’Nion joins RSSL from AWE Aldermaston. He is a chartered chemist and an assessor for the analytical chemistry NVQ from the Royal Society of Chemistry. He is a graduate of Birmingham University.

You may also like

Containment

Technickon provides horizontal laminar flow cabinets in the UK

A pharmaceutical company in the UK has used Technickon to provide cabinets with ISO Class 5 conditions
Design & Build

Taiyo chooses Cytiva FlexFactory in Japanese gene therapy race

Taiyo Pharma Tech has chosen Cytiva's modular biomanufacturing platform for its new gene therapy contract manufacturing facility in Osaka
Containment

ATMPs: Putting pass boxes through their paces

The basics of performance testing PTBs in autologous ATMP plants for GMP compliance looking at a specific case. Frans Saurwalt and Derek Vissers explain the second part of their PTB review
Containment

Growth leads to PBSC office and workshop relocation

PBSC is pleased to announce the relocation of their head office in Huddersfield to a brand- new state-of-the-art office and workshop based in Mirfield, West Yorkshire
Containment

The basics of pass through boxes and GMP application

A look at the fundamental physics applied for adequate contamination control using PTBs. Frans Saurwalt and Derek Vissers from Kropman Contamination Control discuss the details
Design & Build

Pharma process engineering expert DPS Group expands to Switzerland

DPS has opened a new office in Switzerland after business grows in the country
Manufacturing

Donaldson acquires bioprocessing equipment specialist for $46m

The US filtration specialist has acquired Italy-based Solaris Biotechnology
Subscribe now